We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer

This study has been terminated.
(Investigator decision)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00417287
First Posted: January 1, 2007
Last Update Posted: May 19, 2015
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
National Cancer Institute (NCI)
Translational Genomics Research Institute
Information provided by (Responsible Party):
Cascadian Therapeutics Inc.
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2009
  Primary Completion Date: April 2009 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Submission: April 30, 2015